Updated:
Zavation Medical Products
John Franklin's Zavation Medical Products designs spine implants and biologics for ambulatory surgery centers from Flowood, Mississippi.
Zavation Medical Products
Zavation Medical Products operates from Flowood, Mississippi, where John Franklin established the company to serve the orthopedic spine market. The firm develops and manufactures spinal implant systems, including pedicle screws, interbody cages, and expandable devices, alongside a biologics portfolio that covers allografts and synthetic bone grafts. Its customer base spans hospitals, ambulatory surgery centers, and private-practice surgeons. The strategy centers on innovation in minimally invasive spine surgery, targeting the migration of procedures from inpatient to outpatient settings. Product lines include the eZspand Lateral Expandable Interbody System, the Z-Direct MIS Screw System, and Vault C Anterior Cervical Interbody devices. Biologic offerings feature the Zfuze line of demineralized bone matrices and the Allograft Cervical Spacer. The firm deploys capital into R&D, instrumentation sterilization logistics, and a direct sales force covering U.S. metropolitan regions. Headquarters remain in Flowood, with additional operations supporting sterile processing and distribution across the Southeast. In 2022, Zavation completed a facility expansion to accommodate increased manufacturing throughput for its expanding biologics division (per the firm's official communications). Sales and clinical support teams operate nationally, while executive leadership includes tenured spine-industry professionals who previously held roles at major orthopedic firms. Zavation's differentiation lies in its focus on the economics of site-of-care shift. As spine surgery continues moving from hospital inpatient to ambulatory surgery centers, the firm designs instrumentation specifically for smaller footprints and rapid turnover environments—a posture that makes its tray configurations and disposable kits operationally distinct from legacy systems built for large hospital ORs.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Flowood
Corporate office
Flowood, MS, United States
Principals
John W. Franklin
CEO
Sector focus
Frequently asked questions
What specific spine-surgery products does Zavation design and manufacture?
Zavation produces spinal implant systems including pedicle screw and rod constructs, expandable and static interbody cages for lumbar and cervical fusion, and the Z-Direct MIS Screw System for percutaneous procedures. Its biologics portfolio includes the Zfuze demineralized bone matrix product family and allograft spacers sourced through U.S. tissue banks.
Is Zavation positioned for the ambulatory surgery center (ASC) migration in spine?
Yes, Zavation explicitly targets the shift from hospital inpatient to outpatient spine surgery. Its instrumentation trays are designed for smaller-footprint sterile processing departments, and its MIS systems reduce procedural complexity in ASC settings where rapid room turnover and capital-equipment constraints differ from hospital ORs.
How does Zavation source its biologic products?
The firm operates its own biologics division and completed a Flowood facility expansion in 2022 to increase manufacturing capacity. It processes allograft tissue through accredited tissue banks and develops synthetic bone-graft substitutes, maintaining control over the preparation and packaging of demineralized bone matrices and cellular allografts.
Who leads Zavation and what is their industry background?
John W. Franklin serves as CEO and founded the company. Zavation's management team includes executives with prior experience in the orthopedic device divisions of larger medical-technology companies, bringing established relationships with spine-surgeon KOLs and hospital purchasing organizations.
Does Zavation compete directly with major spine companies like Medtronic or NuVasive?
Zavation competes in the same spine-surgery device market but differentiates through ASC-specific instrumentation and a biologics portfolio designed for smaller institutions. It typically competes on surgeon preference, tray cost, and per-case disposable economics rather than on the capital-equipment scale of major navigation or robotics platforms.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: